COMING NEXT:

European Academy of Dermatology & Venereology

With over 12'000 members and an active community of more than 17'000 professionals around the world, our goal is to be the trusted source for proven scientific advancements and practices in the prevention, diagnosis, and treatment of skin and venereal diseases.

EADV is committed to building the international community that develops, shares, and adopts best practices within dermatology and venereology.

Skin and venereal diseases are continuously evolving, as are the science and practices for preventing, diagnosing and treating them. Advancements are being made every day that have the potential to have a significant impact on the ongoing battle to improve skin and sexual health around the world.  Enabling these advancements to be validated and ensuring all professionals adopt the best practices ultimately moves dermatology and venereology forward.

EADV and its international community of passionate professionals define and spread best practices in dermatology and venereology for the benefit of all.  We are a true platform for collaboration and progress across borders and sub-specialties.

Expert task forces shape standards and develop best practice guidelines, while our events, publications, and educational courses share them with our members and the broader community so they can adopt them for maximum impact.

EADV, Together for better

EADV LATEST NEWS:

Online elections

Elections: Board Members

Voting EADV Members from Belgium, Bulgaria, Estonia, Latvia, Lithuania, Russian Federation, Serbia, Spain, Sweden, Ukraine and United Kingdom are called to cast their vote by 4 September 2025 23:59 CEST.
Voters receive emails from Civica Election Services (CES): @cesvotes.com.

JEADV august 2025 is online

Vol 39 Issue 8 of the JEADV is online

See the latest updates on skin & venereal diseases from JEADV, our high-ranking international journal.
In this issue: hidradenitis suppurativa, granular parakeratosis, EADV task force on Hair Diseases position statement, BCC, and more.